Corporate News 21-May-24
Board of ERIS Lifesciences approves NCD issuance up to Rs 1250 cr
At meeting held on 21 May 2024
The Board of ERIS Lifesciences at its meeting held on 21 May 2024 has approved issuance of non-convertible debentures (NCDs) for an amount aggregating up to Rs 1250 crore in one or multiple series through private placement.
Previous News
ERIS Lifesciences consolidated net profit rises 1.08% in the December 2022 quarter
( Results - Announcements 18-Jan-23 07:36 )
ERIS Lifesciences acquires Biocon Biologics' Nephrology and Dermatology biz
( Corporate News - 10-Nov-23 13:29 )
Volumes spurt at ERIS Lifesciences Ltd counter
( Hot Pursuit - 03-Oct-22 11:00 )
ERIS Lifesciences consolidated net profit rises 8.47% in the March 2024 quarter
( Results - Announcements 21-May-24 17:48 )
ERIS Lifesciences allots 12,703 equity shares under ESOP
( Corporate News - 07-Jul-23 11:32 )
Eris Lifesciences gains after decent Q1 results
( Hot Pursuit - 29-Jul-19 10:09 )
ERIS Lifesciences to declare Quarterly Result
( Corporate News - 22-Jan-19 10:54 )
Eris Lifesciences ends with 0.32% discount
( IPO Centre - IPO News 29-Jun-17 16:07 )
Lemon Tree Hotels Ltd leads losers in 'A' group
( Hot Pursuit - 17-Nov-21 15:00 )
ERIS Lifesciences schedules board meeting
( Corporate News - 21-Jul-21 14:05 )
Eris Lifesciences IPO Subscribed 3.25 times
( IPO Centre - IPO News 20-Jun-17 16:46 )
Other Stories
Tridhya Tech to convene board meeting
03-Jul-24 20:06
Sonu Infratech schedules EGM
03-Jul-24 19:59
Sakuma Exports to convene AGM
03-Jul-24 19:59
Time Technoplast repays commercial paper
03-Jul-24 18:31
Board of Aditya Vision approves stock split and listing of share on NSE
03-Jul-24 18:24
Pricol director resigns
03-Jul-24 18:21
Board of VMS Industries recommends first interim dividend
03-Jul-24 17:49
Lakshmi Machine Works to declare Quarterly Result
03-Jul-24 17:44
Modison to convene AGM
03-Jul-24 17:43
Sybly Industries to discuss results
03-Jul-24 17:43
Back
Top
